Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. The company is headquartered in Chicago, Illinois and currently employs 2,400 full-time employees. The company went IPO on 2024-06-14. The firm provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Its product lines include genomics, data, and artificial intelligence applications (AI). Its genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction (PCR), profiling, molecular genotyping, and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.
Follow-Up Questions
What is the price performance of TEM stock?
The current price of TEM is $79.41, it has decreased 6% in the last trading day.
What are the primary business themes or industries for Tempus AI Inc?
Tempus AI Inc belongs to Life Sciences Tools & Services industry and the sector is Health Care
What is Tempus AI Inc market cap?
Tempus AI Inc's current market cap is $13.7B
Is Tempus AI Inc a buy, sell, or hold?
According to wall street analysts, 13 analysts have made analyst ratings for Tempus AI Inc, including 5 strong buy, 6 buy, 7 hold, 0 sell, and 5 strong sell
